Merak Capital, a Saudi-based investment firm licensed by the Capital Market Authority, has led a $1.65 million investment round in Hakeem Health alongside Sanabil 500, supporting the company’s mission to advance AI-driven healthcare innovation across the GCC.

Hakeem Health is a healthcare technology company developing an AI-powered medical assistant designed to deliver real-time, evidence-based clinical insights at the point of care in multiple languages. Its flagship platform, HakeemDx, integrates directly with hospital systems including electronic medical records (EMRs) and laboratory platforms to provide bilingual (Arabic/English) clinical decision support, helping clinicians make faster and more accurate decisions, reduce medical errors, and improve patient outcomes.

The company operates on a scalable SaaS model and is targeting institutional adoption across hospitals, universities, and healthcare payers, with a strong focus on expanding across key regional markets including Saudi Arabia, the UAE, and Egypt. With more than 2,000 hospitals in the region, Hakeem Health is positioned for significant growth as healthcare systems increasingly adopt AI-powered tools to improve efficiency and care quality.

Also read: HHC Earns Elite National Distinction for Cardiac Surgery

Bilal Adi, Founder and CEO of Hakeem Health, said “The investment will accelerate deployment of HakeemDx across GCC healthcare systems and support the company’s mission to help clinicians make better decisions, faster, ultimately improving patient care outcomes.”

Abdulelah Alshareef, Principal of Venture Capital at Merak Capital, said “The investment reflects the growing importance of AI in healthcare, particularly in enhancing clinical decision-making and improving productivity within healthcare systems.”

Click here to join our WhatsApp channel here

The investment also aligns with Saudi Arabia’s Vision 2030 objectives, supporting digital transformation and the development of knowledge-based industries across the region.